Skip to content
Home
Leadership
Locations
Careers
Investors
Media
Press Releases
SEC Filings
Governance
Board Committee
Board of Directors
Governance Documents
Investor Relations Contacts
Investor Materials
Analyst Coverage
Benchmark – Bill Sutherland
Maxim Group – Anthony Vendetti
Freedom Capital Markets – Gene Mannheimer
Contact
Nutex Health
Home
Leadership
Locations
Careers
Investors
Media
Press Releases
SEC Filings
Governance
Board Committee
Board of Directors
Governance Documents
Investor Relations Contacts
Investor Materials
Analyst Coverage
Benchmark – Bill Sutherland
Maxim Group – Anthony Vendetti
Freedom Capital Markets – Gene Mannheimer
Contact
Posts in March 5, 2026
by
919496pwpadmin
March 5, 2026
NUTEX HEALTH REPORTS 2025 FINANCIAL RESULTS AND ANNOUNCES SECOND STOCK REPURCHASE PROGRAM
FULL YEAR 2025 HIGHLIGHTS: Total revenue of $875.3 million for the year 2025 versus $479.9 million […]
0
read more
